RE:“Second mouse gets the cheese “Could Matt Coffey have been referring to the BioNTech / Genentech mRNA + atezolizumab combination in the treatment of resectable pancreatic cancer as the first mouse?
https://stockhouse.com/companies/bullboard/oncy/oncolytics-biotech-inc?postid=35977702